Skip to main content

Advertisement

Fig. 2 | Critical Care

Fig. 2

From: Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants

Fig. 2

a Distribution of rivaroxaban concentrations found at different Hemochron® Signature POCT results of prothrombin time/international normalized ratio (PT/INR) and activated clotting time plus (ACT+) test cards and at different anti-Xa activities (n = 118 samples). b Distribution of dabigatran concentrations found at different Hemochron® Signature POCT results of PT/INR and ACT+ test cards, and at different Hemoclot assay results (n = 168 samples)

Back to article page